Insider Transactions in Q4 2021 at Natus Medical Inc (NTUS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Dong Chune Christopher Chung Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,213
-2.87%
|
$27,899
$23.73 P/Share
|
|
Dec 31
2021
|
Dong Chune Christopher Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,363
+5.29%
|
$54,349
$23.73 P/Share
|
|
Dec 31
2021
|
Austin Francis Noll Iii Executive VP and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,602
-1.28%
|
$36,846
$23.73 P/Share
|
|
Dec 31
2021
|
Austin Francis Noll Iii Executive VP and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
3,676
+2.85%
|
$84,548
$23.73 P/Share
|
|
Dec 31
2021
|
Benjamin Drew Davies Executive VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,486
-3.89%
|
$57,178
$23.73 P/Share
|
|
Dec 31
2021
|
Benjamin Drew Davies Executive VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,252
+7.6%
|
$120,796
$23.73 P/Share
|
|
Dec 09
2021
|
Dong Chune Christopher Chung Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,787
-22.79%
|
$271,101
$23.08 P/Share
|
|
Dec 09
2021
|
Dong Chune Christopher Chung Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,787
+18.56%
|
$235,740
$20.68 P/Share
|
|
Oct 01
2021
|
Benjamin Drew Davies Executive VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,664
-4.35%
|
$66,600
$25.86 P/Share
|